Abstract
1.0 Summary of guidelines 2.0 Introduction 3.0 Aims of TB treatment 4.0 Diagnostic tests 5.0 Type and duration of TB treatment 6.0 Drug–drug interactions 7.0 Overlapping toxicity profiles of antiretrovirals and TB therapy 8.0 Drug absorption 9.0 When to start HAART 10.0 Directly observed therapy (DOT) 11.0 Management of relapse, treatment failure and drug resistance 12.0 Pregnancy and breast-feeding 13.0 Treatment of latent TB infection – HAART, anti-tuberculosis drugs or both? 14.0 Immune reconstitution inflammatory syndrome (IRIS) 15.0 Prevention and control of transmission 16.0 Death and clinico-pathological audit 17.0 Tables 18.0 Key points 19.0 References
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have